Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × avelumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 2 Ureteral Neoplasms 2 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Osteosarcoma 1 Neoplasm Metastasis 1 Metastatic Urothelial Cancer 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Merkel Cell 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

pembrolizumab 30 Paclitaxel 12 Carboplatin 10 Cisplatin 7 Pemetrexed 5 Capecitabine 5 Saline Solution 4 Oxaliplatin 4 Gemcitabine 4 Fluorouracil 4 Docetaxel 4 Albumin-Bound Paclitaxel 4 patritumab deruxtecan 3 lenvatinib 3 Leucovorin 3 Bevacizumab 3 130-nm albumin-bound paclitaxel 3 olaparib 2 liposomal doxorubicin 2 Irinotecan 2 Histamine H2 Antagonists 2 Histamine Antagonists 2 Glucose 2 Dexamethasone 2 Cetuximab 2 Acetaminophen 2 zanidatamab 1 trastuzumab deruxtecan 1 tislelizumab 1 efineptakin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡